HYDERABAD, India; March 13, 2023: Mylan Laboratories Limited (a Viatris Company) has been recognized as a Great Place to Work^® in India for the second year in a row by the Great Place to Work Institute India. The certification reaffirms Viatris' commitment to fostering an engaging and inclusive work environment where employees feel valued, supported, and heard. The achievement is a testament to Viatris’ efforts in creating a positive workplace culture, promoting employee well-being and providing career development opportunities.

Great Place to Work^® is a global authority on workplace culture. Since 1992, it has surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. In India, the institute partners with more than 1,400 organizations annually across over 22 industries to help them build cultures designed to deliver sustained business results.

According to the Great Place to Work^® Trust Index© Employee Survey, which evaluated Viatris across five categories - credibility, respect, fairness, pride, and collaboration - more than 80% of respondents expressed that they think Viatris India is a Great Place to Work!

Commenting on the certification, Udbhav Ganjoo, Head of HR - Global Operations India Emerging Asia & Access Markets, said, “We are delighted to receive the Great Place to Work certification for the second consecutive year. The recognition is a testament to our continued efforts in building a positive and inclusive work culture and motivates us to continue to improve and innovate while supporting our mission of empowering people worldwide to live healthier at every stage of life. We are grateful to our employees, who are the driving force behind our success, and we remain committed to creating a rewarding and engaging work environment for them.”

About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway^®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.